Pancreatitis News and Research

RSS
Pancreatitis is inflammation of the pancreas. The pancreas is a large gland behind the stomach and close to the duodenum—the first part of the small intestine. The pancreas secretes digestive juices, or enzymes, into the duodenum through a tube called the pancreatic duct. Pancreatic enzymes join with bile—a liquid produced in the liver and stored in the gallbladder—to digest food. The pancreas also releases the hormones insulin and glucagon into the bloodstream. These hormones help the body regulate the glucose it takes from food for energy.

Normally, digestive enzymes secreted by the pancreas do not become active until they reach the small intestine. But when the pancreas is inflamed, the enzymes inside it attack and damage the tissues that produce them.

Pancreatitis can be acute or chronic. Either form is serious and can lead to complications. In severe cases, bleeding, infection, and permanent tissue damage may occur.
Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML

Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML

New data from JANUMET clinical study on type 2 diabetes presented at ADA 2011

New data from JANUMET clinical study on type 2 diabetes presented at ADA 2011

AMT receives CHMP opinion on Glybera Marketing Authorisation Application

AMT receives CHMP opinion on Glybera Marketing Authorisation Application

Simple non-invasive breath test could accurately detect vitamin B12 deficiency

Simple non-invasive breath test could accurately detect vitamin B12 deficiency

EC grants marketing authorization to BYDUREON for treatment of type 2 diabetes

EC grants marketing authorization to BYDUREON for treatment of type 2 diabetes

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Amylin disappointed with U.S. District Court's ruling in BYETTA preliminary injunction

Amylin disappointed with U.S. District Court's ruling in BYETTA preliminary injunction

Amylin's metreleptin clinical study data on partial lipodystrophy presented at ENDO 2011

Amylin's metreleptin clinical study data on partial lipodystrophy presented at ENDO 2011

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Roche, Bristol-Myers Squibb to evaluate YERVOY and vemurafenib treatment for metastatic melanoma

Roche, Bristol-Myers Squibb to evaluate YERVOY and vemurafenib treatment for metastatic melanoma

ARIAD's ponatinib initial Phase 1 study data on acute myeloid leukemia to be presented at ASCO 2011

ARIAD's ponatinib initial Phase 1 study data on acute myeloid leukemia to be presented at ASCO 2011

Repligen announces completion of RG1068 pre-New Drug Application meeting with U.S. FDA

Repligen announces completion of RG1068 pre-New Drug Application meeting with U.S. FDA

Cholesterol drug Niaspan fails to protect heart: Study

Cholesterol drug Niaspan fails to protect heart: Study

Mayoly-Spindler, ProteaBio complete MS1819 Phase I/IIA trial in malabsorption syndrome

Mayoly-Spindler, ProteaBio complete MS1819 Phase I/IIA trial in malabsorption syndrome

U.S. District Court grants temporary restraining order in Amylin's litigation against Lilly

U.S. District Court grants temporary restraining order in Amylin's litigation against Lilly

AMT presents long-term efficacy study of Glybera in treatment of lipoprotein lipase deficiency

AMT presents long-term efficacy study of Glybera in treatment of lipoprotein lipase deficiency

Eli Lilly responds to Amylin's exenatide lawsuit

Eli Lilly responds to Amylin's exenatide lawsuit

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.